The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia

Notwithstanding the introduction of Tyrosine Kinase Inhibitors (TKIs) revolutionized the outcome of Chronic Myeloid Leukemia (CML), one third of patients still suspends treatment for failure response. Recent research demonstrated that several BCR/ABL1-independent mechanisms can sustain resistance, b...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Oncol
Hlavní autoři: Grassi, Susanna, Palumbo, Sara, Mariotti, Veronica, Liberati, Diego, Guerrini, Francesca, Ciabatti, Elena, Salehzadeh, Serena, Baratè, Claudia, Balducci, Serena, Ricci, Federica, Buda, Gabriele, Iovino, Lorenzo, Mazziotta, Francesco, Ghio, Francesco, Ercolano, Giacomo, Di Paolo, Antonello, Cecchettini, Antonella, Baldini, Chiara, Mattii, Letizia, Pellegrini, Silvia, Petrini, Mario, Galimberti, Sara
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2019
Témata:
Oncology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6601352/
https://ncbi.nlm.nih.gov/pubmed/31293972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00532
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky